Acute Leukaemia Clinical Trial
Official title:
Leukemia Cell Cultures for Research of New Anti-cancer Therapies
| NCT number | NCT00993538 |
| Other study ID # | 4452 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | October 9, 2009 |
| Last updated | August 29, 2011 |
| Start date | July 2009 |
The main objective of this project is not only a better understanding of the human leukemic
disease but also to find new anti-leukemic or improve existing ones. This study has, the
following aims:
- To analyze the genetic and epigenetic regulation of the retinoic acid induced cascade
which leads to the expression of TRAIL in blood cells of patients with acute leukemia.
This study will be complemented by the analysis of global gene expression (DNA chips)
and of the DNA methylation state, and by chromatin immunoprecipitation experiences.
- To determine the efficiency of inhibitors of enzymes responsible for the modification
of chromatin (existing and new developments within the European consortium EPITRON
coordinated by Dr Gronemeyer) as inducers of differentiation and / or apoptosis of
leukemic blasts.
- To explore Ikaros genic and functional abnormalities (genomic deletions, mutations,
abnormal transcripts and proteins) in acute leukemia. The aim is to determine if these
abnormalities may play a prognosis role.
| Status | Recruiting |
| Enrollment | 180 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patients with suspected de novo or secondary or relapsed acute leukemia, requiring complementary blood test and bone marrow analysis - Patients older or equal than 28 days - Informed consent signed Exclusion Criteria: - Pregnancy - Breastfeeding |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| France | Service d'Hématologie et d'Oncologie | Strasbourg | |
| France | Service de Pédiaterie - Hôpital de Hautepierre | Strasbourg |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Strasbourg, France |
France,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01890746 -
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
|
Phase 2 | |
| Completed |
NCT02058888 -
Amplification and Selection of Antimicrobial Resistance in the Intestine
|
N/A | |
| Completed |
NCT01521611 -
Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00570999 -
Palifermin After Haploidentical PBSCT
|
Phase 2 | |
| Recruiting |
NCT02123836 -
Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome
|
Phase 1 | |
| Completed |
NCT00795132 -
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
|
Phase 2 |